FDA-Inspected Site

Nulixir Inc.

2 FDA inspections are on record for Nulixir Inc. in Austin, United States.

483· Form 483 issued

Austin, United States · Last updated August 15, 2026

Overview

  • 2 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-06-04.

At a glance

Inspections

2

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
29 May 2026 – 4 Jun 2026Foods & Cosmetics483View 483 →
10 Sep 2025 – 11 Sep 2025Foods & CosmeticsClean

Observations on record

Form 483 observations cited at this site, most recent first.

4 Jun 2026
21 CFR 108.25(c)(1)

Registration

Cited by Khunnathee Stoner

4 Jun 2026
21 CFR 108.25(c)(1)

Registration

Cited by Khunnathee Stoner

4 Jun 2026
21 CFR 111.113(a)(4)

Quality control - calibration; quality; material review, disposition

Cited by Khunnathee Stoner

4 Jun 2026
21 CFR 111.113(a)(4)

Quality control - calibration; quality; material review, disposition

Cited by Khunnathee Stoner

4 Jun 2026
21 CFR 111.205(b)(1)

Master manufacturing record - specifications, quality; packaging, labeling

Cited by Khunnathee Stoner

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 108.25(c)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.113(a)(4)Cited across public-safe Form 483 observations2x
21 CFR 111.205(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.70(b)Cited across public-safe Form 483 observations2x
21 CFR 111.70(e)Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations2x

Full site report

Get the verbatim findings behind Nulixir Inc.'s 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat